Based on a popular parlor game established by renowned French novelist Marcel Proust, where one’s answers were believed to reveal their true inner workings, Enigma brings you our version of the Proust Questionnaire. We sit down with today’s technology leaders to discover what makes them tick. What are you most…

The One Line in your Taxes that Shaped a Year-Long Fight over Healthcare — The year-long GOP effort to repeal the Affordable Care Act (ACA) in 2017 revealed a real, principled divide in our country. Is healthcare a choice or a fundamental right? If it’s a choice, can I choose not to have it? …

While the future of healthcare may seem fraught with uncertainty, the central debate will be a familiar one: what level of government regulation will ensure baseline healthcare access and quality of care, while promoting industry innovation? This post takes a look back at how top healthcare events and developments of…

Originally published on August 24, 2016 on the Enigma blog. Health exchanges, established in 2013 under the Affordable Care Act (ACA) and popularly known as Obamacare, help individuals purchase health insurance plans from a central, state-managed, marketplace. This is particularly beneficial for individuals who are self-employed or don’t receive insurance…

For a critical lens on how drug pricing is set, click here. All views are my own. Mylan CEO Heather Bresch has been vilified by the press these past few weeks for the 400% increase in the price of an EpiPen pack. From all of the headlines and coverage this…

On the morning of August 5, 2016, pharmaceutical giant Bristol Myers-Squibb (BMS) announced that its drug, Opdivo (nivolumab), failed a major lung cancer clinical trial. Almost instantaneously, BMS lost $20 billion in market value — its largest drop in over 14 years. Unlike many other clinical trials where failure is…

“The really important thing about data is the more things you have to connect together, the more powerful it is.” — Tim Berners-Lee, founder of the World Wide Web, TED Talk 2009 Startups are generating types of data never before available in health. But it’s not just the emerging quantity…

The healthcare startup world saw $4.5 billion in venture funding in 2015, up from $4.3B in 2014. These startups all purport to “fix” healthcare. But what does that exactly mean? What do these startups actually do? There’s no simple answer. With the myriad of problems that exist in healthcare, startups…

I’ll be splitting this series over several articles, with each focusing on a different set of the candidates’ drug pricing proposals. To read part 1 of this series on the role of pharmaceutical companies in drug pricing, click here. …